Biotech Active Stocks: Arrowhead Research (NASDAQ:ARWR), Gilead Sciences (NASDAQ:GILD), Novavax (NASDAQ:NVAX), MannKind Corporation (NASDAQ:MNKD)

Arrowhead Research Corp (NASDAQ:ARWR) stock had its “buy” rating reaffirmed by stock analysts at Deutsche Bank in a report issued on Monday, American Banking News.com reports. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was -16.09% in last session and finished the day at $17.37. Traded volume was 7.56million shares in the last session and the average volume of the stock remained 1.44million shares. The beta of … Continue reading Biotech Active Stocks: Arrowhead Research (NASDAQ:ARWR), Gilead Sciences (NASDAQ:GILD), Novavax (NASDAQ:NVAX), MannKind Corporation (NASDAQ:MNKD)

Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day at $26.31. Traded volume was 7,684,553 million shares in the … Continue reading Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Best Stocks: General Motors Company (NYSE:GM), Arrowhead Research Corp. (NASDAQ:ARWR), Emergent BioSolutions, Inc. (NYSE:EBS), Taiwan Semiconductor Manufacturing (NYSE:TSM), NCI Building Systems (NYSE:NCS)

General Motors Company (NYSE:GM) is planning to unveil a concept electric vehicle on Monday that can go 200 miles on a single charge. It would be introduced in 2017 and cost about $30,000. General Motors Company (NYSE:GM) belongs to Consumer Goods sector. Its net profit margin is 3.50% and weekly performance is 2.15%. On last trading day company shares ended up $35.59. General Motors Company … Continue reading Best Stocks: General Motors Company (NYSE:GM), Arrowhead Research Corp. (NASDAQ:ARWR), Emergent BioSolutions, Inc. (NYSE:EBS), Taiwan Semiconductor Manufacturing (NYSE:TSM), NCI Building Systems (NYSE:NCS)

Stocks to Watch : Mitsubishi UFJ Financial Group, Inc. (NYSE:MTU), Arrowhead Research Corp. (NASDAQ:ARWR), Tesla Motors (NASDAQ:TSLA), Magellan Health, Inc. (NASDAQ:MGLN), IBM

On Monday, MUFG Union Bank, N.A., a prime member of Mitsubishi UFJ Financial Group Inc. ( MTU ) announced a strategic affiliation with a business unit of Guggenheim Partners – Guggenheim Investment Advisory (GIA). Through this partnership, MUFG Union Bank will provide world-class alternative investment solutions to its customers with the help of the Guggenheim Alternatives Platform. Mitsubishi UFJ Financial Group, Inc. (NYSE:MTU) belongs to … Continue reading Stocks to Watch : Mitsubishi UFJ Financial Group, Inc. (NYSE:MTU), Arrowhead Research Corp. (NASDAQ:ARWR), Tesla Motors (NASDAQ:TSLA), Magellan Health, Inc. (NASDAQ:MGLN), IBM

Hot Alert : Groupon, Inc. (NASDAQ:GRPN), Himax Technologies, Inc. (NASDAQ:HIMX), Pool Corp. (NASDAQ:POOL), Arrowhead Research Corp. (NASDAQ:ARWR), Shinhan Financial Group Company Limited (NYSE:SHG)

Groupon, Inc. (NASDAQ:GRPN) announced that it intends to hold a conference call to discuss its third quarter 2014 financial results on Thursday, October 30, 2014, at 5:00pm EDT. Groupon, Inc. (NASDAQ:GRPN) belongs to Technology sector. Its net profit margin is -5.00% and weekly performance is -0.30%. On last trading day company shares ended up $6.68. Groupon, Inc. (NASDAQ:GRPN) distance from 50-day simple moving average (SMA50) … Continue reading Hot Alert : Groupon, Inc. (NASDAQ:GRPN), Himax Technologies, Inc. (NASDAQ:HIMX), Pool Corp. (NASDAQ:POOL), Arrowhead Research Corp. (NASDAQ:ARWR), Shinhan Financial Group Company Limited (NYSE:SHG)

Stocks in Focus : Arrowhead Research (NASDAQ:ARWR), Sonus Networks (NASDAQ:SONS), RGC (NASDAQ:RGCO), American Electric Power Co., Inc. (NYSE:AEP), American Science (NASDAQ:ASEI)

Arrowhead Research Corp. (NASDAQ:ARWR) on Aug. 12 announced financial results for its fiscal 2014 third quarter ended June 30, 2014 and provided an update on the Phase 2a study of ARC-520, its RNAi-based candidate for the treatment of chronic hepatitis B infection. Net loss attributable to Arrowhead for the quarter was $11.6 million, or $0.22 per share based on 51.9 million weighted average shares outstanding. … Continue reading Stocks in Focus : Arrowhead Research (NASDAQ:ARWR), Sonus Networks (NASDAQ:SONS), RGC (NASDAQ:RGCO), American Electric Power Co., Inc. (NYSE:AEP), American Science (NASDAQ:ASEI)